The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
Researchers investigating the role of progranulin in cancer progression have previously identified the signaling receptor ...
Audacy on MSN
Bladder cancer 6th most prevalent among U.S. men and until now, there hasn't much advancement in treatment
Bladder cancer is the sixth most prevalent cancer among men in the U.S and ninth overall. Until now, there had not been much advancement in treatment. That all changed with INLEXZO, a small device ...
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...
Neoadjuvant cisplatin-based chemotherapy plus chemoradiotherapy offers a safe, effective bladder-sparing approach with promising long-term outcomes in nonmetastatic MIBC. Median disease-free survival ...
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...
Bladder cancer patient Patrick Delahoussaye is benefiting from a new chemotherapy treatment, called a “pretzel.” ...
Urinary tract infections (UTIs) commonly occur in people who undergo chemotherapy. The treatment can weaken the immune system and damage barriers, such as the skin and mucous membranes, that help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results